Capricor Therapeutics Inc (NASDAQ: CAPR) stock closed at $14.36 on 3/20/25 after a major increase of 17.5%. Moreover, trading volume in this advance was exceptionally high at 289% of normal. The stock has risen 9.9% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Capricor Therapeutics has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Capricor Therapeutics has a very low Appreciation Score of 2 but a very high Power Rating of 92, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment